EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Blood neurofilament light chain as a biomarker for cognitive impairment in adults with epilepsy: Integrated evidence from clinical cohorts in Northeast China and European GWAS data

Zhiqing Chen iD, Yujin Guo iD, Jingyi Yao iD, Jingqi Lin iD, Huaiyu Sun iD, Jiaai Li iD, Wuqiong Zhang iD, Shuai Hou iD, Hongmei Meng iD

Epilepsia · 2026

DOI: 10.1111/epi.18659 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Epilepsia, 2026. Verfasst von Zhiqing Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Neurofilament Proteins, Cognitive Dysfunction, Epilepsy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Jilin Provincial Scientific and Technological Development Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Epilepsy treatment aims not only to control seizures but also to enhance quality of life. However, reliable blood‐based biomarkers for epilepsy‐related cognitive impairment are lacking. This study investigated the association between plasma neurofilament light chain (NfL) levels and cognitive function in epilepsy by integrating evidence from observational and Mendelian randomization (MR) analyses across different populations.

Methods

We conducted a cross‐sectional observational study at the First Hospital of Jilin University, enrolling 152 adults with epilepsy. Demographic and clinical information was collected, and cognitive status and psychological status were assessed using the Montreal Cognitive Assessment (MoCA), Mini‐Mental State Examination (MMSE), Memory and Executive Screening (MES) scale, Hamilton Anxiety Scale (HAMA), and Hamilton Depression Scale (HAMD). Plasma NfL levels were measured using enzyme‐linked immunosorbent assay (ELISA). Statistical analyses included logistic regression, linear regression, and receiver‐operating characteristic (ROC) curve analysis. In parallel, two‐sample MR was performed using genome‐wide association study (GWAS) summary statistics from European cohorts. Shared genetic variants between epilepsy and cognitive impairment were identified using multi‐trait analysis of GWAS (MTAG) and cross‐phenotype association (CPASSOC), and served as instrumental variables to estimate the causal effect on plasma NfL levels.

Results

Plasma NfL levels were significantly higher in the cognitively impaired group. After adjusting for confounders, elevated NfL levels remained independently associated with increased risk of cognitive impairment and inversely correlated with cognitive scores. ROC curve analysis showed high diagnostic accuracy of plasma NfL. MR analysis confirmed a positive causal relationship between epilepsy‐related cognitive impairment and plasma NfL levels. Significance Plasma NfL is associated with cognitive impairment in epilepsy and may serve as an early blood‐based biomarker for identifying cognitive dysfunction in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurofilament ProteinsCognitive DysfunctionEpilepsyHumansMaleFemaleGenome-Wide Association StudyBiomarkersCross-Sectional StudiesAdultMiddle AgedChinaCohort StudiesMendelian Randomization AnalysisEurope

Stichwörter der Autor:innen

Mendelian randomizationbiomarkercognitive impairmentepilepsygenome‐wide association studyneurofilament light chain

Substanzen

Neurofilament ProteinsBiomarkersneurofilament protein L

Autor:innen und Institutionen

  • Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun, China.
  • Human Brain and Tissue Bank, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Department of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Zhiqing Chen, Yujin Guo, Jingyi Yao, Jingqi Lin, Huaiyu Sun, Jiaai Li, Wuqiong Zhang, Shuai Hou, Hongmei Meng

Förderung

  • Jilin Provincial Scientific and Technological Development Program
  • National Natural Science Foundation of China

Zitieren

APA

Chen, Z., Guo, Y., Yao, J., Lin, J., Sun, H., Li, J., Zhang, W., Hou, S., & Meng, H. (2026). Blood neurofilament light chain as a biomarker for cognitive impairment in adults with epilepsy: Integrated evidence from clinical cohorts in Northeast China and European GWAS data. Epilepsia. https://doi.org/10.1111/epi.18659

Vancouver

Chen Z, Guo Y, Yao J, Lin J, Sun H, Li J, et al. Blood neurofilament light chain as a biomarker for cognitive impairment in adults with epilepsy: Integrated evidence from clinical cohorts in Northeast China and European GWAS data. Epilepsia. 2026. doi:10.1111/epi.18659

BibTeX
@article{Chen2026,
  author = {Chen, Zhiqing and Guo, Yujin and Yao, Jingyi and Lin, Jingqi and Sun, Huaiyu and Li, Jiaai and Zhang, Wuqiong and Hou, Shuai and Meng, Hongmei},
  title = {Blood neurofilament light chain as a biomarker for cognitive impairment in adults with epilepsy: Integrated evidence from clinical cohorts in Northeast China and European GWAS data},
  journal = {Epilepsia},
  year = {2026},
  doi = {10.1111/epi.18659}
}
Kostenlos starten →